Details for 2016815196

Up to date per 02.04.2026

Actions

Title / Product Name

KOMBINATIONSTHERAPIEN FÜR BLUTMALIGNOME MIT ANTI-CD38-ANTIKÖRPERN SURVIVIN-INHIBITOREN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016815196

EP Publication Number

3310386

E-Number

1411985

Language

PCT Number

US16038702

Publication Date

25.04.2018 A

21.07.2021 B1

Registration Date

21.07.2021

AT Publication Date

15.08.2021

Application Date

22.06.2016

Registration Number

Priorities

22.06.2015

201562182699 P

06.04.2016

201662319036 P

IPC

A61K 39/395 20060101AFI20181127BHEP

Maximum Duration of Protection

22.06.2036

Owner

Janssen Biotech, Inc.800/850 Ridgeview Drive Horsham, PA 19044US

Representative

No representatives present

Inventor

DOSHI, Parul937 Dewees Lane Chester Springs , PA 19425US

LOKHORST, Henk, M.VU University Medical Center Dept. of hematology Room PK.X. 076 De Boelelaan 1117 1081 HV AmsterdamNL

MUTIS, TunaVU University Medical Center Dept. of hematology Room PK.X. 076 De Boelelaan 1117 1081 HV AmsterdamNL